These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6630594)

  • 1. Pemoline, depressive symptoms, and escape from dexamethasone suppression.
    Farmer P; Unis AS; Hsu G
    J Clin Psychopharmacol; 1983 Oct; 3(5):331-2. PubMed ID: 6630594
    [No Abstract]   [Full Text] [Related]  

  • 2. Depression following pemoline withdrawal in a hyperactive child.
    Brown RT; Borden KA; Spunt AL; Medenis R
    Clin Pediatr (Phila); 1985 Mar; 24(3):174. PubMed ID: 3971647
    [No Abstract]   [Full Text] [Related]  

  • 3. Change from Mg-pemoline to bupropion in a 12-year-old boy with attention-deficit hyperactivity disorder.
    Bloomingdale LM
    J Clin Psychopharmacol; 1990 Oct; 10(5):382-3. PubMed ID: 2124222
    [No Abstract]   [Full Text] [Related]  

  • 4. Pemoline-induced Tourette's disorder: a case report.
    Bachman DS
    Am J Psychiatry; 1981 Aug; 138(8):1116-7. PubMed ID: 6942661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemoline in adult attention deficit hyperactivity disorder: predictors of nonresponse.
    Heiligenstein E; Anders J
    J Am Coll Health; 1997 Mar; 45(5):225-9. PubMed ID: 9069682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.
    Bostic JQ; Biederman J; Spencer TJ; Wilens TE; Prince JB; Monuteaux MC; Sienna M; Polisner DA; Hatch M
    J Child Adolesc Psychopharmacol; 2000; 10(3):205-16. PubMed ID: 11052410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on growth in pemoline-treated children with attention deficit disorder.
    Friedmann N; Thomas J; Carr R; Elders J; Ringdahl I; Roche A
    Am J Dis Child; 1981 Apr; 135(4):329-32. PubMed ID: 7211792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemoline-induced mania.
    Sternbach H
    Biol Psychiatry; 1981 Oct; 16(10):987-9. PubMed ID: 6796134
    [No Abstract]   [Full Text] [Related]  

  • 9. A rare case of dependence on pemoline.
    Bonnet U; Davids E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1340-1. PubMed ID: 16600453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemoline-associated fulminant liver failure: testing the evidence for causation.
    Berkovitch M; Pope E; Phillips J; Koren G
    Clin Pharmacol Ther; 1995 Jun; 57(6):696-8. PubMed ID: 7781270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reaction. Pemoline and dyskinesia.
    Shuster J
    Nursing; 1999 Feb; 29(2):24. PubMed ID: 10085879
    [No Abstract]   [Full Text] [Related]  

  • 12. Pemoline and hepatotoxicity.
    McCurry L; Cronquist S
    Am J Psychiatry; 1997 May; 154(5):713-4. PubMed ID: 9137138
    [No Abstract]   [Full Text] [Related]  

  • 13. Pemoline (Cylert)-induced hepatotoxicity.
    Elitsur Y
    J Pediatr Gastroenterol Nutr; 1990 Jul; 11(1):143-4. PubMed ID: 2388127
    [No Abstract]   [Full Text] [Related]  

  • 14. Pemoline hepatotoxicity in children.
    Marotta PJ; Roberts EA
    J Pediatr; 1998 May; 132(5):894-7. PubMed ID: 9602211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotoxicity due to pemoline (Cylert): a report of two cases.
    Pratt DS; Dubois RS
    J Pediatr Gastroenterol Nutr; 1990 Feb; 10(2):239-41. PubMed ID: 2303976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gilles de la Tourette's disorder associated with pemoline.
    Mitchell E; Matthews KL
    Am J Psychiatry; 1980 Dec; 137(12):1618-9. PubMed ID: 6933864
    [No Abstract]   [Full Text] [Related]  

  • 17. Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity.
    Collier CP; Soldin SJ; Swanson JM; MacLeod SM; Weinberg F; Rochefort JG
    Clin Pharmacokinet; 1985; 10(3):269-78. PubMed ID: 4017397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemoline (Cylert): market withdrawal.
    Hogan V
    CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
    [No Abstract]   [Full Text] [Related]  

  • 19. Pemoline in ADHD.
    Winsberg B; Barbato M
    J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
    [No Abstract]   [Full Text] [Related]  

  • 20. Four cases of severe hepatotoxicity associated with pemoline: possible autoimmune pathogenesis.
    Rosh JR; Dellert SF; Narkewicz M; Birnbaum A; Whitington G
    Pediatrics; 1998 May; 101(5):921-3. PubMed ID: 9565425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.